The nation of Zimbabwe has rejected a substantial US health deal valued at 367 million US dollars (£272m) spanning five years because of Washington's insistence on sensitive information.
This rejection became public after a internal memorandum dated December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
A government spokesperson has since stated that the US was seeking health data for research and commercial gain but was not willing to guarantee the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued negotiations to reach a agreement acceptable to all parties so the country's critical HIV programme can proceed.
Broader Background
This rejection follows a comparable case in neighbouring Kenya, where a court suspended a similar health funding agreement after concerns were raised about the security of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance transparency and accountability.
As per reports, 16 African countries have to date signed these new health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided significant advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment through American-funded initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to share its biological resources and data over an extended period, with no equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," Mangwana explained.
"In essence, our nation would supply the basic resources for medical research without any certainty that the resulting innovations would be accessible to our population if a new pandemic emerge."
Sovereignty and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems already set up through the global health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage further dialogue with our US partners on how subsequent collaboration might be designed in a manner that respects the independence and interests of each country."
Medical Community Reaction
A leading public health body stated it recognised the official position, but recommended that negotiations should continue given that much of the nation's Aids initiatives depended on foreign aid.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it said.
The situation underscores the ongoing challenges between receiving crucial foreign assistance and safeguarding national sovereignty in an ever more interconnected world.